Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Irvine Health Cancer Center-Newport
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Greater Regional Medical Center
mi
from
Creston, IA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Davis Hospital
mi
from
Davis, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Physicians LLC-Samaritan North
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
National Jewish Health-Main Campus
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Saint Mary's Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Crossroads Cancer Center
mi
from
Effingham, IL
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer Partnership
mi
from
Everett, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesee Cancer & Blood Disease Treatment Center, PC
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mountain Blue Cancer Care Center
mi
from
Golden, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Park Ridge Health
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pulmonary Medicine Center of Chattanooga-Hixson
mi
from
Hixson, TN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The Cancer Center of Hawaii-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Diagnostic Center
mi
from
Campbell, CA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeastern Retina Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dean A. McGee Eye Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Institute
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Influenza Vaccination Clinical Trial
Study of Immune Responses to Influenza Vaccination
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
University of Washington Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Delineating Swallowing Impairment and Decline in ALS
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Other Clinical Trial
Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Stem Cell Transplant Complications Clinical Trial
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Smoking Cessation Clinical Trial
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
Status: Enrolling, Phase IV
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
Low Carbohydrate/High Protein Diet to Improve Metabolic Health
Status: Enrolling
Updated: 12/31/1969
UAB
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 1345
mi
from
Miami, FL
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10664
mi
from
North Miami, FL
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10124
mi
from
Spokane, WA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10103
mi
from
Waco, TX
Click here to add this to my saved trials
Infantile Spasm Clinical Trial
A Novel Approach to Infantile Spasms
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry, Other Clinical Trial
Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Beth Israel Deconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Degenerative Disc Disease Clinical Trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Degenerative Disc Disease Clinical Trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Physicians Research Options
mi
from
Draper, UT
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Genesis Medical Center
mi
from
Davenport, IA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
McLaren Flint
mi
from
Flint, MI
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health Cardiovascular Institute
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Turkey Creek Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
MidMichigan Medical Center - Midland
mi
from
Midland, MI
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Santa Monica/UCLA Medical Center and Orthopaedic Hospital
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
UCLA Hematology-Oncology Santa Monica
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Children's Hospital of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Nemours Children's Clinic - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Center for Children's Digestive Health
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Willis-Knighton Physician Network
mi
from
Shreveport, LA
Click here to add this to my saved trials
Dengue Clinical Trial
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Johnson County Clin-Trials
mi
from
Lenexa, KS
Click here to add this to my saved trials
Eating Disorder Clinical Trial
Brain Function in Adolescent Eating Disorders and Healthy Peers
Status: Enrolling
Updated: 11/19/2017
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Severe Osteoarthritis of the Knee Clinical Trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee
Status: Enrolling, Phase III
Updated: 12/19/2017
Heartland Research Associates, LLC
mi
from
Wichita, KS
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
Allergy Partners of North Texas Research
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Accurate Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakes Research
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials